International price comparison of pharmaceuticals 2017 – a volume based analysis of Swedish pharmaceutical prices relative to 19 other European countries.

Emil Aho, Pontus Johansson, Gunilla Rönnholm (Tandvårds- och läkemedelsförmånsverket, TLV)

In this report, TLV presents the results of the analysis of price and volume data for the first quarter of 2014, 2015, 2016 and 2017 in Sweden in comparison with 19 other European countries. The segments analysed are pharmaceuticals not exposed to competition and pharmaceuticals exposed to competition, with the latter including all pharmaceuticals available as substitutable medicines in the product-of-themonth system as per March 2017.

The report should be viewed as a basis for further analysis of the dynamics of Swedish prices and price changes compared to that seen internationally.

The EURIPID collaboration is currently funded by an annual contribution fee of the participants and – for defined tasks and deliverables – a grant of the EU.

This website is part of the project ’826652 Euripid’ which is co-funded by the European Union’s Health Programme (2014-2020).

The content of this website represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.

International price comparison of pharmaceuticals 2017 – a volume based analysis of Swedish pharmaceutical prices relative to 19 other European countries.

Collaborating Across Europe to Ensure Fair, Accessible, and Sustainable Healthcare

© Copyright – EURIPID